Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
June 7, 2014
Alternative polyadenylation in the nervous system: to what lengths will 3' UTR extensions take us?
Pedro Miura, Piero Sanfilippo, Sol Shenker, et al.
RNA (New York, N.Y.)
|
November 20, 2014
IsoSCM: improved and alternative 3' UTR annotation using multiple change-point inference
Sol Shenker, Pedro Miura, Piero Sanfilippo, et al.
Plos Computational Biology
|
September 2, 2015
Analysis of Nearly One Thousand Mammalian Mirtrons Reveals Novel Features of Dicer Substrates
Jiayu Wen, Erik Ladewig, Sol Shenker, et al.
Genome Research
|
March 23, 2013
Widespread and extensive lengthening of 3' UTRs in the mammalian brain
Pedro Miura, Sol Shenker, Celia Andreu-Agullo, et al.
Cell Reports
|
December 30, 2014
Genome-wide analysis of drosophila circular RNAs reveals their structural and sequence properties and age-dependent neural accumulation
Jakub O Westholm, Pedro Miura, Sara Olson, et al.
Cancer Research Communications
|
November 1, 2024
Pan-Cancer Analysis of Homologous Recombination Deficiency in Cell Lines
Anne E Dodson, Sol Shenker, Pamela Sullivan, et al.
Cell Reports
|
June 12, 2012
Global patterns of tissue-specific alternative polyadenylation in Drosophila
Peter Smibert, Pedro Miura, Jakub O Westholm, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 7, 2025
A Precision Gene Engineered B Cell Medicine Producing Sustained Levels of Active Factor IX for Hemophilia B Therapy
Hanlan Liu, Swati Singh, Timothy J Mullen, et al.
Cancer Research
|
October 15, 2024
The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Tumors
Louise Cadzow, Jehrod Brenneman, Erica Tobin, et al.
The Journal of Clinical Investigation
|
December 15, 2023
Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screens
Michael R Schlabach, Sharon Lin, Zachary R Collester, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
June 7, 2014
Alternative polyadenylation in the nervous system: to what lengths will 3' UTR extensions take us?
Pedro Miura, Piero Sanfilippo, Sol Shenker, et al.
RNA (New York, N.Y.)
|
November 20, 2014
IsoSCM: improved and alternative 3' UTR annotation using multiple change-point inference
Sol Shenker, Pedro Miura, Piero Sanfilippo, et al.
Plos Computational Biology
|
September 2, 2015
Analysis of Nearly One Thousand Mammalian Mirtrons Reveals Novel Features of Dicer Substrates
Jiayu Wen, Erik Ladewig, Sol Shenker, et al.
Genome Research
|
March 23, 2013
Widespread and extensive lengthening of 3' UTRs in the mammalian brain
Pedro Miura, Sol Shenker, Celia Andreu-Agullo, et al.
Cell Reports
|
December 30, 2014
Genome-wide analysis of drosophila circular RNAs reveals their structural and sequence properties and age-dependent neural accumulation
Jakub O Westholm, Pedro Miura, Sara Olson, et al.
Cancer Research Communications
|
November 1, 2024
Pan-Cancer Analysis of Homologous Recombination Deficiency in Cell Lines
Anne E Dodson, Sol Shenker, Pamela Sullivan, et al.
Cell Reports
|
June 12, 2012
Global patterns of tissue-specific alternative polyadenylation in Drosophila
Peter Smibert, Pedro Miura, Jakub O Westholm, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 7, 2025
A Precision Gene Engineered B Cell Medicine Producing Sustained Levels of Active Factor IX for Hemophilia B Therapy
Hanlan Liu, Swati Singh, Timothy J Mullen, et al.
Cancer Research
|
October 15, 2024
The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Tumors
Louise Cadzow, Jehrod Brenneman, Erica Tobin, et al.
The Journal of Clinical Investigation
|
December 15, 2023
Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screens
Michael R Schlabach, Sharon Lin, Zachary R Collester, et al.
Page
of 2